Patents by Inventor Yu-Sheng Chao

Yu-Sheng Chao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indole compounds
    Patent number: 7449478
    Abstract: This invention relates to treating peroxisome proliferator-activated receptors related diseases with certain indole compounds. The indole compounds are of formula (I) below. Each variable is defined in the specification.
    Type: Grant
    Filed: December 3, 2004
    Date of Patent: November 11, 2008
    Assignee: National Health Research Institutes
    Inventors: Hsing-Pang Hsieh, Neeraj Mahindroo, Tsu-An Hsu, Chien-Fu Huang, Xin Chen, Yu-Sheng Chao
  • HEPATITIS C VIRUS INHIBITORS
    Publication number: 20080255189
    Abstract: A compound of the following formula: in which R1, R2, R3, U, V, T, W, X, Y, Z, m, n, p, x, y, and z are as defined herein. Also disclosed are (1) a pharmaceutical composition containing such a compound, and (2) a method for treating Hepatitis C virus infection using such a compound.
    Type: Application
    Filed: March 26, 2008
    Publication date: October 16, 2008
    Applicant: National Health Research Institutes
    Inventors: Jyh-Haur Chern, Tsu-An Hsu, Iou-Jiun Kang, Li-Wen Wang, Chung-Chi Lee, Yen-Chun Lee, Yu-Sheng Chao
  • Oxadiazole Compounds
    Publication number: 20080255211
    Abstract: A compound of formula (I): in which A, R1, R2, and R3 are as defined herein. Also disclosed are (1) a pharmaceutical composition containing such a compound, and (2) a method for treating a cannabinoid receptor-mediated disorder using such a compound.
    Type: Application
    Filed: March 18, 2008
    Publication date: October 16, 2008
    Applicant: National Health Research Institutes
    Inventors: Kak-Shan Shia, Cheng-ming Chu, Jing-po Tsao, Yu-Sheng Chao, Jen-shin Song
  • Pyrrolidine compounds
    Patent number: 7425633
    Abstract: A compound of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, T, X, Y, and Z are as defined herein. Also disclosed is a method for inhibiting dipeptidyl peptidase IV or for treating Type II diabetes with such a compound.
    Type: Grant
    Filed: August 28, 2006
    Date of Patent: September 16, 2008
    Assignee: National Health Research Institutes
    Inventors: Weir-Torn Jiaang, Yu-Sheng Chao, Hsing-Pang Hsieh
  • THIOUREA COMPOUNDS
    Publication number: 20080113975
    Abstract: This invention relates to thiourea compounds of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to treat hepatitis C virus infection.
    Type: Application
    Filed: August 15, 2007
    Publication date: May 15, 2008
    Applicant: National Health Research Institutes
    Inventors: Jyh-Haur Chern, Tsu-An Hsu, Iou-Jiun Kang, Li-Wen Wang, Chung-Chi Lee, Yen-Chun Lee, Yu-Sheng Chao
  • THIOUREA COMPOUNDS
    Publication number: 20080096875
    Abstract: This invention relates to thiourea compounds of formula (II) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to treat hepatitis C virus infection.
    Type: Application
    Filed: August 15, 2007
    Publication date: April 24, 2008
    Applicant: National Health Research Institutes
    Inventors: Jyh-Haur Chern, Tsu-An Hsu, Iou-Jiun Kang, Li-Wen Wang, Chung-Chi Lee, Yen-Chun Lee, Yu-Sheng Chao
  • PYRAZOLE COMPOUNDS
    Publication number: 20080090809
    Abstract: This invention relates to pyrazole compounds of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.
    Type: Application
    Filed: October 2, 2007
    Publication date: April 17, 2008
    Applicant: National Health Research Institutes
    Inventors: Kak-Shan Shia, Chia-Liang Tai, Jing-po Tsao, Wan-ping Hsieh, Shi-liang Tseng, Yu-Sheng Chao, Ming-Shiu Hung
  • THIOPHENE COMPOUNDS
    Publication number: 20080090810
    Abstract: This invention relates to thiophene compounds of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.
    Type: Application
    Filed: October 2, 2007
    Publication date: April 17, 2008
    Applicant: National Health Research Institutes
    Inventors: Kak-Shan Shia, Chia-Liang Tai, Jyh-hsiung Liao, Ming-Shiu Hung, Yu-Sheng Chao
  • SELENOPHENE COMPOUNDS
    Publication number: 20080021031
    Abstract: This invention relates to selenophene compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.
    Type: Application
    Filed: July 3, 2007
    Publication date: January 24, 2008
    Applicant: National Health Research Institute
    Inventors: Kak-Shan Shia, Jing-Po Tsao, Chia-Liang Tai, Wan-Ping Hsieh, Ming-Shiu Hung, Jen-Shin Song, Yu-Sheng Chao
  • Pyrrolidine derivatives
    Publication number: 20070093492
    Abstract: Pyrrolidine compounds described herein and methods for using them to inhibit dipeptidyl peptidase IV or treat Type II diabetes.
    Type: Application
    Filed: October 6, 2006
    Publication date: April 26, 2007
    Inventors: Weir-Torn Jiaang, Yu-Sheng Chao, Ting-Yueh Tsai
  • Pyrrolidine compounds
    Publication number: 20070082932
    Abstract: A compound of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, T, X, Y, and Z are as defined herein. Also disclosed is a method for inhibiting dipeptidyl peptidase IV or for treating Type II diabetes with such a compound.
    Type: Application
    Filed: August 28, 2006
    Publication date: April 12, 2007
    Inventors: Weir-Torn Jiaang, Yu-Sheng Chao, Hsing-Pang Hsieh
  • Anti-tumor compounds
    Publication number: 20060148801
    Abstract: Compounds of the following formula: wherein A, D, Q, T, U, V, W, X, Y, Z, R1, and ---- are as defined herein. This invention also relates to a method of inhibiting tubulin polymerization, or treating cancer or an angiogenesis-related disorder with one of these compounds.
    Type: Application
    Filed: December 15, 2005
    Publication date: July 6, 2006
    Inventors: Hsing-Pang Hsieh, Yu-Sheng Chao, Jing-Ping Liou, Jang-Yang Chang, Yen-Shih Tung
  • Pyrrolidine compounds
    Publication number: 20050222222
    Abstract: A compound of the following formula: wherein R1 R2, R3, R4, R5, R6, W, X, Y, Z, m, n, and p are as defined herein. This invention also covers methods for inhibiting dipeptidyl peptidase IV or VIII, or treating Type II diabetes with such a compound.
    Type: Application
    Filed: March 9, 2005
    Publication date: October 6, 2005
    Inventors: Weir-Torn Jiaang, Xin Chen, Su-Ying Wu, Yu-Sheng Chao, Hsing-Pang Hsieh
  • Indole compounds
    Publication number: 20050124675
    Abstract: This invention relates to treating peroxisome proliferator-activated receptors related diseases with certain indole compounds. The indole compounds are of formula (I) below. Each variable is defined in the specification.
    Type: Application
    Filed: December 3, 2004
    Publication date: June 9, 2005
    Inventors: Hsing-Pang Hsieh, Neeraj Mahindroo, Tsu-An Hsu, Chien-Fu Huang, Xin Chen, Yu-Sheng Chao
  • Drug combination therapy
    Publication number: 20050107461
    Abstract: The instant invention provides a drug combination comprised of an HMG-CoA reductase inhibitor in combination with an ACAT inhibitor, which is useful for treating or preventing Alzheimer's disease.
    Type: Application
    Filed: March 7, 2003
    Publication date: May 19, 2005
    Inventors: Tian-Quan Cai, Yu-Sheng Chao